Rheumatoid arthritis surveillance in Ontario: monitoring the burden, quality of care and patient outcomes through linkage of administrative health data
Widdifield J, Bernatsky S, Bombardier C, Paterson M. Healthc Q. 2015; 18(3):7-10.
Publications
Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study
Haroon NN, Paterson JM, Li P, Inman RD, Haroon N. Ann Intern Med. 2015; 163(6):409-16. Epub 2015 Aug 11.
Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996–2012
Albaum JM, Levesque LE, Gershon AS, Liu G, Cadarette SM. Osteoporos Int. 2015; 26(12):2845-52. Epub 2015 Jul 3.
Fibromyalgia and the risk of a subsequent motor vehicle crash
Redelmeier DA, Zung JD, Thiruchelvam D, Tibshirani RJ. J Rheumatol. 2015; 42(8):1502-10. Epub 2015 May 15.
Osteoporosis management and fractures in the Métis of Ontario, Canada
Jandoc R, Jembere N, Khan S, Russell SJ, Allard Y, Cadarette SM. Arch Osteoporos. Epub 2015 Apr 25.
Increased risk of mycobacterial infections associated with anti-rheumatic medications
Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, Li P, Marchand-Austin A, Bombardier C, Marras TK. Thorax. 2015; 70(7): 677-82. Epub 2015 Apr 24.
Patterns of use for brand-name versus generic oral bisphosphonate drugs in Ontario over a 13-year period: a descriptive study
Fraser LA, Albaum JM, Tadrous M, Burden AM, Shariff SZ, Cadarette SM. CMAJ Open. 2015; 3(1):E91-96.
Canadian administrative health data can identify patients with myasthenia gravis
Breiner A, Young J, Green D, Katzberg HD, Barnett C, Bril V, Tu K. Neuroepidemiology. 2015; 44(2):108-13.
Trends in excess mortality among patients with rheumatoid arthritis in Ontario, Canada
Widdifield J, Bernatsky S, Paterson JM, Tomlinson G, Tu K, Kuriya B, Thorne JC, Pope JE, Hollands S, Bombardier C. Arthritis Care Res (Hoboken). 2015; 67(8):1047-53. Epub 2015 Jan 26.
Uptake and characteristics of zoledronic acid and denosumab patients and physicians in Ontario, Canada: impact of drug formulary access
Burden AM, Tadrous M, Calzavara A, Cadarette SM. Osteoporos Int. 2015; 26(5):1525-33. Epub 2015 Jan 21.